H35.13 Retinopathy of prematurity, stage 2

Name of the Condition

• Retinopathy of prematurity, stage 2

Summary

Retinopathy of prematurity (ROP) is a disorder affecting premature infants, characterized by abnormal blood vessel development in the retina. Stage 2 represents a mild to moderate phase where abnormal blood vessel growth is present but not yet severe. This stage may involve structural changes in the retina, such as a ridge or demarcation line, and requires monitoring to assess progression. Vision loss is uncommon at this stage, but timely intervention can prevent advancement to more severe forms.

Causes

ROP is caused by the incomplete growth of retinal blood vessels in premature infants. The retina, which normally develops blood vessels by full-term birth, may not have fully vascularized in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth. Stage 2 reflects a transitional phase where vascular changes are evident but not yet advanced.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In stage 2, ROP is typically asymptomatic and may not present obvious signs. Infants with this stage often show no visible abnormalities in eye appearance or behavior. Diagnosis relies on routine screening, as symptoms like abnormal eye movements or leukocoria (white pupil) are rare at this stage.

Diagnosis

Diagnosis is made through routine retinal screening in premature infants, typically using indirect ophthalmoscopy. Stage 2 is identified by the presence of a ridge or demarcation line separating vascularized and avascular retina, with mild vascular abnormalities. Screening guidelines recommend exams based on gestational age and postnatal risk factors.

Treatment Options

Stage 2 ROP often requires close observation without immediate intervention, as many cases resolve spontaneously. Treatment may be considered if progression to more severe stages (e.g., stage 3) is suspected. Options include laser therapy or anti-VEGF injections for advanced cases, though these are less common in stage 2.

Prognosis and Follow-Up

Prognosis for stage 2 ROP is generally favorable, with many cases stabilizing or regressing. However, ongoing monitoring is essential to detect progression. Follow-up exams are scheduled based on clinical judgment, typically every 1-2 weeks, until the retina is fully vascularized or the disease regresses.

Complications

While stage 2 ROP rarely causes immediate complications, progression to more severe stages (e.g., retinal detachment) can occur if left untreated. Long-term risks include myopia, strabismus, or vision impairment, though these are uncommon in isolated stage 2 cases.

Lifestyle & Prevention

Prevention focuses on minimizing risk factors, such as careful oxygen management in neonatal care. For infants with stage 2 ROP, maintaining regular follow-up and avoiding additional stressors (e.g., infection) supports recovery. No specific lifestyle modifications are required for the infant.

When to Seek Professional Help

Seek immediate evaluation if screening suggests progression to stage 3 or higher, or if symptoms like leukocoria or abnormal eye movements develop. Early intervention is critical to prevent vision loss.

Tips for Medical Coders

Use H35.13 for confirmed stage 2 retinopathy of prematurity. Document the stage clearly, as staging impacts coding and clinical management. Ensure documentation supports the diagnosis, including screening results and any observed retinal changes. Avoid coding for unspecified stages when stage 2 is confirmed.